Point of Care Diagnostics Market to 2027 Major Product Development covering Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products

Global point of care diagnostics market, based on the product, was segmented as, glucose monitoring products, infectious disease testing products, cardiometabolic testing products, pregnancy and fertility testing products, coagulation testing products, tumor/cancer marker testing products, cholesterol testing products, urinalysis testing products, hematology testing products, and other POC products. In 2018, the glucose monitoring products segment held a largest market share of the point of care diagnostics market, by product. This segment is also expected to dominate the market in 2027 owing to the increasing diabetic patients. However, infectious disease testing product market is expected to grow at significant rate, in the forecast period 2019 to 2027. Moreover, Infectious disease rapid test kits are widely available for a wide variety of prophlogistic pathogen targets, including bacterial, viral, fungal, protozoan, and other disease agents.

The Insight Partners adds "Point of Care Diagnostics Market to 2027" to its database. This report is a comprehensive evaluation of the market trends of industry. The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market.

Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00006394?utm_source=OpenPR&utm_medium=Simran

According to a new market research study titled ‘Point of Care Diagnostics Market to 2027 – Global Analysis and Forecasts by Product, Prescription Mode, and End User.’ The global point of care diagnostics market is expected to reach US$ 70.89 Bn in 2027 from US$ 26.60 Bn in 2018. The market is estimated to grow with a CAGR of 11.8% from 2019-2027. The report highlights the trends prevalent in the global point of care diagnostics market and the factors driving the market along with those that act as deterrents to its growth.

The market for point of care diagnostics is expected to grow, owing to factors such as increasing incidences of infectious diseases, product launches and product development and increasing number of CLIA-waived POC tests over the years. In In addition, the emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years.

Point-of-care testing (POCT) plays critical roles in diagnosis, treatment, and prevention of infectious diseases. POC testing can be used to detect several major pathogens, including malarial parasites; human immunodeficiency virus (HIV); human papillomavirus (HPV); dengue, Ebola, and Zika viruses; and Mycobacterium tuberculosis (TB bacteria). HIV has infected over 40 million people worldwide; ~85% of this population resides in developing countries, which have a limited availability of clinical diagnostics and antiretroviral therapy (ART) monitoring platforms. To narrow down the diagnostic time, companies are developing POC test kits and reagents, for instance, Food and Drug Administration (FDA) has approved the ARCHITECT HIV Ag/Ab EIA, a fourth-generation assay, introduced by Abbott Laboratories. Increasing incidences of infectious diseases such as HIV is the major global public health issue. In 2018, World Health Organization (WHO) having claimed that more than 32 million HIV people are diagnosed, out of which 770 000 people died. At the end of 2018, 1.7 million people were reported to be newly infected globally, including 62% adults and 54% children. According to HIV and AIDS organization (AVERT), in 2018, 1.1 million US residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. As per European Centre for Disease Prevention and Control, ~2 million people in Europe were infected with HIV in 2018. Such increase in the incidence of infectious diseases is expected to create a demand for point of care test kits across the world.

BY PRODUCT
• Glucose Monitoring
• Infectious Disease Testing
o HIV Testing Products
o Influenza Testing Products
o Sexually Transmitted Disease (STD) Testing Products
o Hepatitis C Testing Products
o Healthcare-Associated Infection (HAI) Testing Products
o Tropical Disease Testing Products
o Respiratory Infection Testing Products
o Other Infectious Disease Testing Products
• Cardiometabolic Testing
• Pregnancy And Fertility Testing
• Coagulation Testing
• Tumor/Cancer Marker Testing
• Cholesterol Testing
• Urinalysis Testing
• Hematology Testing
• Other POC Products

BY PRESCRIPTION MODE
• Prescription-Based Testing
• OTC Testing

BY END USER
• Professional Diagnostic Centers
• Home Care
• Research Laboratories
• Others

Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00006394?utm_source=OpenPR&utm_medium=Simran

Contact us –
Phone : +1-646-491-9876
Email Id : sales@theinsightpartners.com
Website: https://www.theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

This release was published on openPR.